Department of Pediatrics, Bronx-Lebanon Hospital Center, Albert Einstein College of Medicine, Bronx, NY 10457, USA.
Pediatr Nephrol. 2012 Jun;27(6):981-9. doi: 10.1007/s00467-011-2097-1. Epub 2012 Feb 26.
This study describes the incidence, clinical and demographic characteristics, and spectrum of chronic kidney disease (CKD) in youths with perinatal HIV-1 infection.
Retrospective analysis between May 1993 and December 2006 of subjects with renal disease followed in the Pediatric AIDS Clinical Trials Group 219/219C multicenter study examining the long-term consequences of perinatal HIV infection. Diagnosis confirmation was made utilizing a questionnaire mailed to research sites. Participants with CKD of other etiology than HIV were excluded. Outcome measures were biopsy-diagnosed CKD and, in the absence of biopsy, HIV-associated nephropathy (HIVAN) using established clinical criteria.
Questionnaires on 191 out of 2,102 participants identified 27 cases of CKD: 14 biopsy-diagnosed and 6 clinical cases of HIVAN, and 7 biopsy-diagnosed cases of immune complex-mediated kidney disease (lupus-like nephritis, 3; IgA nephropathy, 2; membranous nephropathy, 2). Incidence rates for CKD associated with HIV in pre-highly active antiretroviral therapy (HAART) (1993-1997) and HAART (1998-2002, 2003-2006) eras were 0.43, 2.84, and 2.79 events per 1,000 person years respectively. In multivariate analysis, black race and viral load ≥100,000 copies/mL (rate ratios 3.28 and 5.05, p ≤ 0.02) were associated with CKD.
A variety of immune complex-mediated glomerulonephritides and HIVAN occurs in this population. Black race and uncontrolled viral replication are risk factors for CKD associated with HIV.
本研究描述了围产期 HIV-1 感染的青少年慢性肾脏病(CKD)的发病情况、临床和人口统计学特征及谱。
1993 年 5 月至 2006 年 12 月,对参与儿科艾滋病临床试验组 219/219C 多中心研究的肾病患者进行回顾性分析,该研究旨在检查围产期 HIV 感染的长期后果。诊断确认是通过邮寄给研究地点的问卷进行的。排除了其他病因引起的 CKD 患者。观察指标为活检确诊的 CKD 和在无活检情况下,采用已建立的临床标准诊断的 HIV 相关性肾病(HIVAN)。
对 2102 名参与者中的 191 名进行了问卷调查,确定了 27 例 CKD:14 例活检确诊,6 例临床确诊的 HIVAN,7 例活检确诊的免疫复合物介导的肾脏疾病(狼疮样肾炎 3 例;IgA 肾病 2 例;膜性肾病 2 例)。在未接受高效抗逆转录病毒治疗(HAART)(1993-1997 年)和 HAART(1998-2002 年、2003-2006 年)时期,与 HIV 相关的 CKD 的发病率分别为 0.43、2.84 和 2.79 例/1000 人年。多变量分析显示,黑人种族和病毒载量≥100000 拷贝/ml(危险比 3.28 和 5.05,p≤0.02)与 CKD 相关。
该人群中存在多种免疫复合物介导的肾小球肾炎和 HIVAN。黑人种族和未控制的病毒复制是与 HIV 相关的 CKD 的危险因素。